Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorio italiano biochimico farmaceutico lisapharma s.p.a. - glutatiÓn (sÓdico) - glutatiÓn (sÓdico)....600.00 mg / agua para inyectables....3.00 ml

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorio italiano biochimico farmaceutico lisapharma s.p.a. - metilprednisolona (sodio succinato) - metilprednisolona (sodio succinato)....500 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorio italiano biochimico farmaceutico lisapharma s.p.a. - ibuprofeno (lisinato) - ibuprofeno (lisinato)....400,00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorio italiano biochimico farmaceutico lisapharma s.p.a. - succinato sodico de (metilprednisolona) - succinato sodico de (metilprednisolona)....20 mg / agua....c.s.p. 2 ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

laboratorio italiano biochimico farmaceutico lisapharma s.p.a. - glyceryl (glyceryl trinitrate) - concentrate for solution for infusion - 5mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

laboratorio italiano biochimico farmaceutico lisapharma s.p.a. - atracurium (atracurium besylate) - solution for i/v infusion - 10mg/ml

Israel - English - Ministry of Health

genmedix , israel - calcitonin salmon; calcitonin salmon - solution for injection - calcitonin salmon 100 iu/ml; calcitonin salmon 100 iu/ml - calcitonin (salmon synthetic) - calcitonin (salmon synthetic) - calcitonin is indicated for:• prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures.• for the treatment of paget's disease, only in patients who do not respond to alternative treatments or for whom such treatments are not suitable, for example those with severe renal impairment.• treatment of hypercalcemia of malignancy. calcitonin is indicated for:• prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures.• for the treatment of paget's disease, only in patients who do not respond to alternative treatments or for whom such treatments are not suitable, for example those with severe renal impairment.• treatment of hypercalcemia of malignancy.

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios liconsa, s.a. - terbinafine - tablets - 250 milligram - antifungals for systemic use - antifungals for systemic use - it is indicated in the treatment of the following skin and nail fungal infections: treatment of tinea corporis, tinea cruris and tinea pedis, when oral therapy is considered appropriate depending on the site, severity or extent of the infection and for the treatment of onychomycosis caused by dermatophytes

European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a - live ge- tk- double-gene-deleted bovine herpes virus type 1, strain ceddel: 106.3–107.3 ccid50 - immunologicals - cattle - for the active immunisation of cattle from three months of age against bovine herpes virus type 1 (bohv-1) to reduce the clinical signs of infectious bovine rhinotracheitis (ibr) and field virus excretion.onset of immunity: 21 days after completion of the basic vaccination scheme.duration of immunity: 6 months after completion of the basic vaccination scheme

European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a. - inactivated bordetella bronchiseptica, strain 833cer / recombinant type-d pasteurella-multocida toxin (pmtr) - immunologicals - pigs (gilts and sows) - for the passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with bordetella-bronchiseptica and pasteurella-multocida infections during the fattening period. challenge studies have demonstrated that passive immunity lasts until piglets are six weeks of age while in clinical field trials, the beneficial effects of vaccination (reduction in nasal lesion score and weight loss) are observed until slaughter.